Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
about
On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringSafety and tolerability of antiepileptic drug treatment in children with epilepsy.The application of capillary electrophoresis techniques in toxicological analysis.Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment.A simple and cost-effective HPLC-UV method for the detection of levetiracetam in plasma/serum of patients with epilepsy.The Influence of Solid Microneedles on the Transdermal Delivery of Selected Antiepileptic Drugs.An Analytical Study to Correlate Serum Levels of Levetiracetam with Clinical Course in Patients with EpilepsySelected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients.Advances in epilepsy treatment: lacosamide pharmacokinetic profile.Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.Pharmacological considerations in the use of stiripentol for the treatment of epilepsy.Determination of Levetiracetam in Human Plasma by Dispersive Liquid-Liquid Microextraction Followed by Gas Chromatography-Mass Spectrometry.Determination of valproic acid in human plasma using dispersive liquid-liquid microextraction followed by gas chromatography-flame ionization detection.Utilization patterns of antiepileptic drugs among adult epileptic patients at a tertiary hospital in Oman.Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’.Noninvasive Sampling of Gabapentin by Reverse Iontophoresis
P2860
Q27024074-E369C35D-05E5-4EBE-A5ED-5FF672822E44Q34281872-6EC4F28B-933C-4A0B-BEDC-20DA29136E9BQ35168632-0E3324A8-650B-4A57-8CBB-F0361D5D4AC9Q36275095-602D7864-288F-4E11-9822-A1DC66592CF1Q36308262-A8A661FF-2034-4451-BDF0-C6DF9D0CD334Q37542311-9C93E8F2-9A0E-4F22-8F13-62B2160133F0Q37593001-A64D79AF-C535-48DE-9651-C4FC9C193BE6Q37824886-7D051887-6986-4162-8A26-74D1D7403D1FQ38244248-9C38FABA-17D2-46EB-8A6D-8B86989DD125Q38719986-180B74EC-EDF1-4252-9870-7D8DEE5AC953Q38738877-415DFBBD-6CDB-4002-BB7B-5FE0A9893009Q41619687-2303BC1E-2BEB-4326-89DE-3DCCF4F153B6Q41954363-FE70176E-6B0F-4C31-99DC-BEBB7C03583FQ46489939-31F97587-6F69-4588-91F7-1A06178F11C4Q55221688-BFE7B9E1-C947-45B3-B53F-252A8F48BAF3Q56035503-4A8EB857-6227-4BD2-84DE-0E8D422CAB4A
P2860
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
@ast
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
@en
type
label
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
@ast
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
@en
prefLabel
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
@ast
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
@en
P2860
P356
P1433
P1476
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
@en
P2860
P304
P356
10.3390/PH3061909
P577
2010-06-01T00:00:00Z